123 related articles for article (PubMed ID: 34591391)
21. Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis.
Zhou YX; Wang C; Mao LW; Wang YL; Xia LQ; Zhao W; Shen J; Chen J
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C690-C701. PubMed ID: 29466670
[TBL] [Abstract][Full Text] [Related]
22. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
23. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
24. LncRNA RBAT1 reduces chemosensitivity of cancer cells to carboplatin/paclitaxel by sponging miR‑27b in endometrial carcinoma.
Fan L; Wang C; Zhan P; Liu Y
J Ovarian Res; 2023 Jul; 16(1):147. PubMed ID: 37501162
[TBL] [Abstract][Full Text] [Related]
25. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
Yang X; Xing G; Liu S; Li B; He Y; Wang F
Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
[TBL] [Abstract][Full Text] [Related]
26. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
Wang L; Zhao S; Mingxin YU
Pharmazie; 2019 May; 74(5):295-300. PubMed ID: 31109400
[TBL] [Abstract][Full Text] [Related]
27. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
Wang GF; Wen LN
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
30. LncROR Promotes Bladder Cancer Cell Proliferation, Migration, and Epithelial-Mesenchymal Transition.
Chen Y; Peng Y; Xu Z; Ge B; Xiang X; Zhang T; Gao L; Shi H; Wang C; Huang J
Cell Physiol Biochem; 2017; 41(6):2399-2410. PubMed ID: 28463831
[TBL] [Abstract][Full Text] [Related]
31. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
32. [Interference of long noncoding RNA FOXCUT inhibits epithelial-mesenchymal transformation and induces mitochondrial injury in nasopharyngeal carcinoma cells].
Gao L; Zhang X; Dou S; Yue X; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(9):1334-1341. PubMed ID: 34658347
[TBL] [Abstract][Full Text] [Related]
33. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
34. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
35. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
[TBL] [Abstract][Full Text] [Related]
36. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
37. LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.
Shen L; Wu Y; Li A; Li L; Shen L; Jiang Q; Li Q; Wu Z; Yu L; Zhang X
Oncol Rep; 2020 Oct; 44(4):1343-1354. PubMed ID: 32945477
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge to regulate epithelial-mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3.
Yang C; Shen S; Zheng X; Ye K; Sun Y; Lu Y; Ge H
FASEB J; 2019 Sep; 33(9):10490-10504. PubMed ID: 31311326
[TBL] [Abstract][Full Text] [Related]
39. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
